US2023141825A1PendingUtilityA1
Emulsion based drug screening
Est. expiryJan 13, 2040(~13.5 yrs left)· nominal 20-yr term from priority
C12Q 1/025C12Q 1/6869G01N 33/5008C12Q 2600/106
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods and systems for drug screening by segregating single cells into droplets simultaneously and providing candidate compound to the single cells to measure cellular response. Methods of the present invention combine template particles with a plurality of single cells in a tube, generate in the tube monodispersed droplets simultaneously that encapsulate a single one of the template particles and single one of the single cells, provide to the single cells one or more candidate compounds, and measure a cellular response to the one or more candidate compounds.
Claims
exact text as granted — not AI-modified1 . A method for drug screening, the method comprising:
combining template particles with a plurality of single cells in a tube; generating in the tube a plurality of monodispersed droplets simultaneously that encapsulate a single one of the template particles and single one of the single cells; providing to the single cells one or more candidate compounds; and measuring a cellular response to the one or more candidate compounds.
2 . The method of claim 1 , wherein the one or more candidate compounds are provided to a droplet by the single template particle encapsulated by the droplet.
3 . The method of claim 2 , wherein the one or more candidate compounds are provided to the droplet from the surface of the template particle.
4 . The method of claim 2 , wherein the template particles comprise one or more compartments and one or more candidate compounds are provided to the cells from a compartment of the template particle.
5 . The method of claim 1 , wherein the one or more candidate compounds are provided to the single cells after generating the plurality of monodispersed droplets.
6 . The method of claim 5 , comprising the step of releasing the single cells from the monodispersed droplets prior to providing to the single cells one or more candidate drug compounds.
7 . The method of claim 1 , wherein combining template particles and generating droplets comprises:
combining the template particles with the single cells in a first fluid; adding a second fluid to the first fluid; and shearing the fluids to generate a plurality of monodispersed droplets simultaneously that contain a single one of the template particles and a single one of the single cells.
8 . The method of claim 7 , wherein the first fluid and the second fluid are immiscible.
9 . The method of claim 7 , wherein the first fluid comprises an aqueous phase fluid.
10 . The method of claim 7 , wherein the second fluid comprises an oil.
11 . The method of claim 7 , wherein shearing the fluids comprises vortexing, shaking, flicking, stirring, or pipetting.
12 . The method of claim 1 , wherein the method further comprises releasing nucleic acid molecules from the single cells and sequencing the nucleic acid molecules.
13 . The method of claim 12 , wherein releasing nucleic acid molecules from the single cells comprises lysing each of the single cells contained within the monodisperse droplets to release the nucleic acid molecules.
14 . The method of claim 13 , wherein measuring a cellular response comprises sequencing the nucleic acid molecules.
15 . The method of claim 14 , wherein the nucleic acid molecules are mRNA molecules.
16 . The method of claim 15 , wherein measuring a cellular response comprises quantifying a plurality of distinct mRNA molecules in the cells associated with the drug response.
17 . The method of claim 16 , wherein measuring a cellular response comprises generating a gene expression profile for each of the single cells.
18 . The method of claim 1 , wherein measuring a cellular response comprises quantifying a plurality of protein molecules in the cells associated with a drug response.
19 . The method of claim 18 , wherein measuring a cellular response comprises generating a protein expression profile for each of the single cells.
20 . The method of claim 1 , wherein the tube is a conical centrifuge tube.
21 - 28 . (canceled)Join the waitlist — get patent alerts
Track US2023141825A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.